The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sarissa Capital Master Fund Ii Lp since 2021.
This trader's CIK number is 1811636.
At the time of last reporting, Sarissa Capital Master Fund Ii Lp was the 10% Owner of Iterum Therapeutics Plc. (stock ticker symbol ITRM).
Also see all insider trading activities at Iterum Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ITRM | 0 | $0 | 20,619,949 | $50,007,284 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-12 | ITRM | Sale | 10,619,949 | 2.27 | 24,107,284 |
| 2021-02-11 | ITRM | Sale | 10,000,000 | 2.59 | 25,900,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sarissa Capital Master Fund Ii Lp (10% Owner of Iterum Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.